Laboratoires Lehning Acquires Laboratoire Lescuyer from Abenex

October 1, 2020

Groupe Lehning (Laboratoires Lehning) has acquired French dietary-supplements maker Laboratoire Lescuyer from private equity firm Abenex; Abenex and co-investors Bpifrance and Ouest Croissance sold their entire stakes. Isabelle de Carmantrand and the Lescuyer family reinvested alongside the buyer; the deal is intended to combine complementary therapeutic areas and distribution channels to accelerate brand growth.

Buyers
Groupe Lehning (Laboratoires Lehning)
Targets
Laboratoire Lescuyer
Sellers
Abenex, Bpifrance, Ouest Croissance
Industry
Pharmaceuticals
Location
Nouvelle-Aquitaine, France
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.